Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries-Reference-Cited by-同舟云学术

Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries

Published:2002-09 Issue:9 Volume:11 Page:1303-1313
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Kaufmann Gilbert R¹,Smith Don²,Bucher Heiner C¹,Phanuphak Praphan³,Sendi Pedram P⁴,Mbidde Edward K⁵,Cooper David A⁶,Battegay Manuel⁷

Affiliation:

1. Basel Center for HIV Research, Division of Infectious Diseases, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland

2. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia

3. Thai Red Cross, AIDS Research Centre, Chulalongkorn University, 1871 Rama IV Road Bangkok 10330, Thailand

4. Institute for Medical Technology Assessment, Erasmus University, PO Box 1738, 3000 DR Rotterdam, The Netherlands

5. Uganda Cancer Institute, PO Box 39, Kampala, Uganda

6. The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok 10330, Thailand

7. Basel Center for HIV Research, Division of Infectious Diseases, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland. mbattegay@uhbs.ch

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.11.9.1303

Reference29 articles.

1. Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

2. Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir

3. Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir, or Both in Human Immunodeficiency Virus–Infected Adults with Virologic Failure on Indinavir: AIDS Clinical Trials Group Study 359

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand;Journal of Antimicrobial Chemotherapy;2006-07-01

2. Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue Treatment;Clinical Infectious Diseases;2005-03-01

3. Interrupting highly active antiretroviral therapy in patients with HIV;Expert Review of Anti-infective Therapy;2005-01

4. Use of antiretroviral therapy among HIV positive individuals living in British Columbia;AIDS Care;2004-10-01

5. THE IMMUNOLOGICAL AND VIROLOGICAL RESPONSE IN HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTED INDIAN INDIVIDUALS ON HAART THERAPY: A ONE-YEAR FOLLOW UP STUDY;Indian Journal of Medical Microbiology;2003-10